Skip to main content

Table 1 Characteristics of women admitted for treatment of hyperemesis gravidarum at Haukeland University Hospital 2002–2019, n = 1,064

From: Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019

 

Mean (SD)

Age (years)

28.6 (5.2)

Pre-pregnancy BMI (kg/m2)a

24.5 (4.7)

Weight change at first admission (% of pre-pregnancy weight)

-5.8 (4.4)

Gestational length at first admission (days)c

66 (19)

 

Median (IQR)

Gravidityd

2 (1; 3)

Paritye

1 (0; 1)

Previous pregnancies with hyperemesisf

1 (1; 2)

Number of hospitalizations

1 (1; 2)

Total number of days in hospitalg

2 (1; 5)

Total number of antiemetics pre-hospitalh

1 (1; 2)

Total number of antiemetics while hospitalizedi

2 (1; 3)

 

n (%)

Readmitted once or more

341 (32)

Termination of pregnancy

61 (5.7)

  1. Abbreviations: n number, SD standard deviation, IQR interquartile range, BMI body mass index
  2. an = 19 missing values
  3. bn = 16 missing values
  4. cn = 2 missing values
  5. dn = 4 missing values
  6. en = 1 missing value
  7. fn = 320 (30%) had previous pregnancies with HG
  8. gNumber of days hospitalized, including readmissions
  9. hn = 532 (50%) using antiemetics prior to first hospitalization for hyperemesis
  10. in = 1,016 (95%) using antiemetics during hospital stay, including readmissions